BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37409887)

  • 1. Galectin-1 Mediates Chronic STING Activation in Tumors to Promote Metastasis through MDSC Recruitment.
    Nambiar DK; Viswanathan V; Cao H; Zhang W; Guan L; Chamoli M; Holmes B; Kong C; Hildebrand R; Koong AJ; von Eyben R; Plevritis S; Li L; Giaccia A; Engleman E; Le QT
    Cancer Res; 2023 Oct; 83(19):3205-3219. PubMed ID: 37409887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
    Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visualization and quantification of
    Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
    Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression.
    Shi H; Zhang J; Han X; Li H; Xie M; Sun Y; Liu W; Ba X; Zeng X
    Int J Cancer; 2017 Mar; 140(6):1370-1383. PubMed ID: 27885671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E3 ligase TRIM28 promotes anti-PD-1 resistance in non-small cell lung cancer by enhancing the recruitment of myeloid-derived suppressor cells.
    Liang M; Sun Z; Chen X; Wang L; Wang H; Qin L; Zhao W; Geng B
    J Exp Clin Cancer Res; 2023 Oct; 42(1):275. PubMed ID: 37865804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL10 conditions alveolar macrophages within the premetastatic niche to promote metastasis.
    Shang C; Sun Y; Wang Y; Shi H; Han X; Mo Y; Wang D; Ke Y; Zeng X
    Cancer Lett; 2022 Jul; 537():215667. PubMed ID: 35398531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment.
    Kho VM; Mekers VE; Span PN; Bussink J; Adema GJ
    Cell Immunol; 2021 Apr; 362():104298. PubMed ID: 33592541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TFF3 mediates the NF-κB/COX2 pathway to regulate PMN-MDSCs activation and protect against necrotizing enterocolitis.
    Liu J; Yang Q; Chen Z; Lv S; Tang J; Xing Z; Shi M; Lei A; Xiao G; He Y
    Eur J Immunol; 2021 May; 51(5):1110-1125. PubMed ID: 33547649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma.
    Liu X; Tang R; Xu J; Tan Z; Liang C; Meng Q; Lei Y; Hua J; Zhang Y; Liu J; Zhang B; Wang W; Yu X; Shi S
    Gut; 2023 Nov; 72(12):2329-2343. PubMed ID: 37541772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neddylation pathway promotes myeloid-derived suppressor cell infiltration via NF-κB-mCXCL5 signaling in lung cancer.
    Zhou L; Lin X; Zhang L; Chen S; Chen J; Zhou Z; Tang A; Ruan J; Wang X; Chen B
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109329. PubMed ID: 36252470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis.
    Zeng X; Zhou J; Xiong Z; Sun H; Yang W; Mok MTS; Wang J; Li J; Liu M; Tang W; Feng Y; Wang HK; Tsang SW; Chow KL; Yeung PC; Wong J; Lai PB; Chan AW; To KF; Chan SL; Xia Q; Xue J; Chen X; Yu J; Peng S; Sung JJ; Kuang M; Cheng AS
    Cell Mol Immunol; 2021 Apr; 18(4):1005-1015. PubMed ID: 32879468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xiaoliu Pingyi Pecipe Inhibits Lung Pre-Metastatic Niche Formation and Prevents Myeloid-Derived Suppressor Cells Recruitment.
    Li H; Yang F; Zhang L; Zhao R; Li X; Li H
    Integr Cancer Ther; 2023; 22():15347354231187000. PubMed ID: 37431869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloma-Secreted Galectin-1 Potently Interacts with CD304 on Monocytic Myeloid-Derived Suppressor Cells.
    Lim JY; Kim TW; Ryu DB; Park SS; Lee SE; Kim BS; Min CK
    Cancer Immunol Res; 2021 May; 9(5):503-513. PubMed ID: 33771821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Myeloid-Derived Suppressor Cells in Tumor Growth and Metastasis.
    Bayik D; Lee J; Lathia JD
    Exp Suppl; 2022; 113():189-217. PubMed ID: 35165865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy.
    Sun L; Clavijo PE; Robbins Y; Patel P; Friedman J; Greene S; Das R; Silvin C; Van Waes C; Horn LA; Schlom J; Palena C; Maeda D; Zebala J; Allen CT
    JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion.
    Zhang CX; Ye SB; Ni JJ; Cai TT; Liu YN; Huang DJ; Mai HQ; Chen QY; He J; Zhang XS; Zeng YX; Li J; Cui J
    Cell Death Differ; 2019 Nov; 26(11):2314-2328. PubMed ID: 30816302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs.
    Su MT; Kumata S; Endo S; Okada Y; Takai T
    Oncoimmunology; 2022; 11(1):2060907. PubMed ID: 35402083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression.
    Li N; Liu Q; Han Y; Pei S; Cheng B; Xu J; Miao X; Pan Q; Wang H; Guo J; Wang X; Zhang G; Lian Y; Zhang W; Zang Y; Tan M; Li Q; Wang X; Xiao Y; Hu G; Jiang J; Huang H; Qin J
    Nat Commun; 2022 Nov; 13(1):7281. PubMed ID: 36435834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micellar nanoparticles inhibit the postoperative inflammation, recurrence and pulmonary metastasis of 4T1 breast cancer by blocking NF-κB pathway and promoting MDSCs depletion.
    Lu Z; Ma L; Mei L; Ren K; Li M; Zhang L; Liu X; He Q
    Int J Pharm; 2022 Nov; 628():122303. PubMed ID: 36265660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A8/A9 activate key genes and pathways in colon tumor progression.
    Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
    Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.